Abstract | BACKGROUND: METHODS: We screened chemosensitivity-related genes by comparing gene-expression profiles of patients with short-term tumor response or nonresponse to IC (n = 95) using microarray analysis. Chemosensitivity-related genes were quantified by digital expression profiling in a training cohort (n = 342) to obtain a gene signature. We then validated this gene signature in the clinical trial cohort (n = 187) and an external independent cohort (n = 240). Tests of statistical significance are 2-sided. RESULTS: We identified 43 chemosensitivity-related genes associated with the short-term tumor response to IC. In the training cohort, a 6-gene signature was developed that was highly accurate at predicting the short-term tumor response to IC (area under the curve [AUC] = 0.87, sensitivity = 87.5%, specificity = 75.6%). We further found that IC conferred failure-free survival benefits only in patients in the benefit group (hazard ratio [HR] = 0.54, 95% confidence interval [CI] = 0.34 to 0.87; P = .01) and not on those in the no-benefit group (HR = 1.25, 95% CI = 0.62 to 2.51; P = .53). In the clinical trial cohort, the 6-gene signature was also highly accurate at predicting the tumor response (AUC = 0.82, sensitivity = 87.5%, specificity = 71.8%) and indicated failure-free survival benefits. In the external independent cohort, similar results were observed. CONCLUSIONS: The 6-gene signature can help select beneficiaries of IC and lay a foundation for a more individualized therapeutic strategy for locoregionally advanced nasopharyngeal carcinoma patients.
|
Authors | Yuan Lei, Ying-Qin Li, Wei Jiang, Xiao-Hong Hong, Wen-Xiu Ge, Yuan Zhang, Wei-Han Hu, Ya-Qin Wang, Ye-Lin Liang, Jun-Yan Li, William C S Cho, Jing-Ping Yun, Jing Zeng, Jie-Wei Chen, Li-Zhi Liu, Li Li, Lei Chen, Fang-Yun Xie, Wen-Fei Li, Yan-Ping Mao, Xu Liu, Yu-Pei Chen, Ling-Long Tang, Ying Sun, Na Liu, Jun Ma |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 113
Issue 4
Pg. 471-480
(04 06 2021)
ISSN: 1460-2105 [Electronic] United States |
PMID | 33094348
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: [email protected]. |
Topics |
- Adult
- Aged
- Area Under Curve
- Cohort Studies
- Drug Resistance, Neoplasm
(genetics)
- Female
- Gene Expression
- Gene Expression Profiling
- Humans
- Induction Chemotherapy
- Male
- Middle Aged
- Nasopharyngeal Carcinoma
(drug therapy, genetics, mortality, pathology)
- Nasopharyngeal Neoplasms
(drug therapy, genetics, mortality, pathology)
- Sensitivity and Specificity
- Treatment Outcome
|